Replies to post #66309 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Too bad Elite has the patents for theirs..

[NASDAQ2020]

JT had direct dialog with the FDA thru WASBURN&WOODCOCK

What we've done is just separate them into two different beads. I mean, that's why we are excited about it. It's different. Quite frankly, it's much more straightforward, and it uses the pharmacologic approach, which clearly the FDA likes the best, because it's understandable in terms of the science. Okay?
You don't get high, because the agonist competes with the opioid for the receptors on the brain. Okay? Again, straightforward theory